Skip to content
10-Q

Quarterly Report

Cantabio Pharmaceuticals Inc.

0001424884-17-000006

← back to feed
Filed
Feb 10, 2017 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2017 · Dec 31, 2016 26.81M sh
Stockholders Equity Q3 2017 · Dec 31, 2016 −$596.51K
Stockholders Equity Q3 2017 · Mar 31, 2016 −$369.78K
Current Liabilities Q3 2017 · Dec 31, 2016 $607.3K
Current Liabilities Q3 2017 · Mar 31, 2016 $421.89K
Total Liabilities Q3 2017 · Dec 31, 2016 $607.3K
Total Liabilities Q3 2017 · Mar 31, 2016 $421.89K
Current Assets Q3 2017 · Dec 31, 2016 $10.76K
Current Assets Q3 2017 · Mar 31, 2016 $52.11K
Total Assets Q3 2017 · Dec 31, 2016 $10.76K
Total Assets Q3 2017 · Mar 31, 2016 $52.11K
Operating Cash Flow Q3 2017 · Dec 31, 2015 −$383.61K
Cash And Equivalents Q3 2017 · Dec 31, 2015 $100.86K
Cash And Equivalents Q3 2017 · Mar 31, 2015 $209
Sga Expense restated Q3 2017 · Dec 31, 2015 $169.03K
Sga Expense restated Q3 2017 · Dec 31, 2015 $420.42K
Rd Expense restated Q3 2017 · Dec 31, 2015 $4.37K
Rd Expense restated Q3 2017 · Dec 31, 2015 $6.7K
Net Income restated Q3 2017 · Dec 31, 2015 −$65.51K
Net Income restated Q3 2017 · Dec 31, 2015 −$319.23K